Diabetic Medicine 2013; 30(12): 1510-1511

The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis—what happens next? A personal viewpoint

R. E. J. Ryder¹, P. Sen Gupta^1,2, K. Y. Thong¹ on behalf of the ABCD nationwide exenatide^* and liraglutide^† audit contributors

¹Department of Diabetes and Endocrinology, City Hospital, Birmingham, UK

²Diabetes Research Group, King’s College, London, UK

^*The exenatide audit contributors are listed in reference 2.

^†The liraglutide audit contributors are listed in reference 3.